搜尋結果
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters· 3 日前G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer ...
Alnylam Shares Soar After Drug Meets Goal in Heart Disease Trial
Bloomberg· 3 日前A study released Monday found that Alnylam’s vutrisiran, which is sold as Amvuttra, helped ...
U.K. Patients To Get $3.3 Million Hemophilia Gene Therapy For Free
Forbes· 14 小時前An English drugs cost regulator has approved a $3.3 million (£2.6 million) gene therapy for use ...
Cosmetic Ozempic Use Under Fire in Europe Amid Drug Shortages
Bloomberg· 1 日前Have a confidential tip for our reporters? The European Union’s drug regulator urged countries ...
What It Will Take To End The Battle Over The $54 Billion U.S. Discount Drug Program
Forbes· 2 日前A recent congressional hearing on 340B is the latest iteration of a standoff between two ...
Council Post: Emerging Trends In AI In Biotech
Forbes· 4 日前Additionally, my tenure as a researcher at the Robert Langer Lab at MIT, where I focused on .. ...
Startup’s ‘Fentanyl Vaccine’ Aims to Block Drug’s Highs, Overdoses
Bloomberg· 1 日前Ovax has raised $10 million to develop and market academic work on addiction treatment.
Novo Nordisk's Wegovy weight loss drug approved in China
CNBC· 2 日前... Medical Products Administration "recently" approved the weekly injectable drug, ...
US appeals court revives Amarin heart-drug patent lawsuit over Hikma generic
Reuters· 2 日前Amarin Pharma convinced a U.S. appeals court on Tuesday to resurrect a patent infringement ...
Sonia's AI chatbot steps in for therapists
TechCrunch· 2 小時前On the other hand, it’s well-established that the relationship between therapist and client — the human ...